Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir. Wong GL, Hui VW, Yip TC, Lui GC, et al. Gastroenterology 2023;164:151-153.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wong GL, Hui VW, Yip TC, Lui GC, et al. Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir. Gastroenterology 2023;164:151-153.
PMID: 36126688